Serum soluble Toll-like receptor 4 and the risk of hepatocellular carcinoma in hepatitis C virus patients

INTRODUCTION: Soluble Toll-like receptor 4 (sTLR4) is a negative regulator of TLR4 signalling that has been reported in different diseases. In this study, we aimed to assess the serum levels of sTLR4 in hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) and to investigate the correlation...

Descripción completa

Detalles Bibliográficos
Autores principales: Elkammah, Maha, Gowily, Ahmed, Okda, Tarek, Houssen, Maha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836282/
https://www.ncbi.nlm.nih.gov/pubmed/33531868
http://dx.doi.org/10.5114/wo.2020.102818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836282/
https://www.ncbi.nlm.nih.gov/pubmed/33531868
http://dx.doi.org/10.5114/wo.2020.102818

Ejemplares similares